BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28655939)

  • 1. Increased Anti-HSP60 and Anti-HSP70 Antibodies in Women with Unexplained Recurrent Pregnancy Loss.
    Matsuda M; Sasaki A; Shimizu K; Kamada Y; Noguchi S; Hiramatsu Y; Nakatsuka M
    Acta Med Okayama; 2017 Jun; 71(3):201-208. PubMed ID: 28655939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating anti-heat-shock-protein antibodies in normal pregnancy and preeclampsia.
    Molvarec A; Derzsy Z; Kocsis J; Boze T; Nagy B; Balogh K; Makó V; Cervenak L; Mézes M; Karádi I; Prohászka Z; Rigó J
    Cell Stress Chaperones; 2009 Sep; 14(5):491-8. PubMed ID: 19205928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of uterine artery Doppler velocimetry indices and plasma adrenomedullin level in women with unexplained recurrent pregnancy loss.
    El-mashad AI; Mohamed MA; Farag MA; Ahmad MK; Ismail Y
    J Obstet Gynaecol Res; 2011 Jan; 37(1):51-7. PubMed ID: 21083839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta2-Glycoprotein 1 as a marker of antiphospholipid syndrome in women with recurrent pregnancy loss.
    Franklin RD; Hollier N; Kutteh WH
    Fertil Steril; 2000 Mar; 73(3):531-5. PubMed ID: 10689008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of platelet parameters, coagulation markers, antiphospholipid syndrome, and thyroid function in palestinian women with recurrent pregnancy loss.
    Najjar AA; Hassouna I; Srour MA; Ibrahim HM; Assi RY; Abd El Latif HM
    BMC Pregnancy Childbirth; 2023 Jun; 23(1):459. PubMed ID: 37340363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of midluteal phase uterine artery hemodynamics in patients with recurrent pregnancy loss.
    Yang W; Wu Z; Yu M; Peng X; Lu W; Feng W; Kang X
    J Obstet Gynaecol Res; 2019 Jul; 45(7):1230-1235. PubMed ID: 30977230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine and placental blood flow indexes and antinuclear autoantibodies in unexplained recurrent pregnancy loss: should they be investigated in pregnancy as correlated potential factors? A retrospective study.
    Bruno V; Ticconi C; Martelli F; Nuccetelli M; Capogna MV; Sorge R; Piccione E; Pietropolli A
    BMC Pregnancy Childbirth; 2020 Jan; 20(1):44. PubMed ID: 31959152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum heat shock protein and anti-heat shock protein antibody levels in aging.
    Rea IM; McNerlan S; Pockley AG
    Exp Gerontol; 2001 Feb; 36(2):341-52. PubMed ID: 11226747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D deficiency may be a risk factor for recurrent pregnancy losses by increasing cellular immunity and autoimmunity.
    Ota K; Dambaeva S; Han AR; Beaman K; Gilman-Sachs A; Kwak-Kim J
    Hum Reprod; 2014 Feb; 29(2):208-19. PubMed ID: 24277747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased serum heat shock protein 60 levels in newly diagnosed immune thrombocytopenia patients.
    Dolasik I; Birtas Atesoglu E; Tarkun P; Mehtap O; Keski H; Dogru A; Hacihanefioglu A
    Platelets; 2015; 26(3):220-3. PubMed ID: 24749912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin A anti-beta2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death.
    Lee RM; Branch DW; Silver RM
    Am J Obstet Gynecol; 2001 Sep; 185(3):748-53. PubMed ID: 11568809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated blood flow resistance in uterine arteries of women with unexplained recurrent pregnancy loss.
    Habara T; Nakatsuka M; Konishi H; Asagiri K; Noguchi S; Kudo T
    Hum Reprod; 2002 Jan; 17(1):190-4. PubMed ID: 11756386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of women with recurrent pregnancy losses and antiphospholipid antibody syndrome.
    Kwak-Kim J; Agcaoili MS; Aleta L; Liao A; Ota K; Dambaeva S; Beaman K; Kim JW; Gilman-Sachs A
    Am J Reprod Immunol; 2013 Jun; 69(6):596-607. PubMed ID: 23521391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High basal estradiol level and FSH/LH ratio in unexplained recurrent pregnancy loss.
    Gürbüz B; Yalti S; Ozden S; Ficicioglu C
    Arch Gynecol Obstet; 2004 Jul; 270(1):37-9. PubMed ID: 12756582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat shock proteins and heat shock protein-antibody complexes in placental tissues.
    Ziegert M; Witkin SS; Sziller I; Alexander H; Brylla E; Härtig W
    Infect Dis Obstet Gynecol; 1999; 7(4):180-5. PubMed ID: 10449265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune causes of recurrent pregnancy loss.
    Festin MR; Limson GM; Maruo T
    Kobe J Med Sci; 1997 Oct; 43(5):143-57. PubMed ID: 9642970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to plasminogen and tissue plasminogen activator in women with recurrent pregnancy loss.
    Bu C; Zhang C; Li Z; Gao L; Xie Z; Cai G
    Clin Exp Immunol; 2007 Jul; 149(1):31-9. PubMed ID: 17425656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating heat shock protein and heat shock protein antibody levels in established hypertension.
    Pockley AG; De Faire U; Kiessling R; Lemne C; Thulin T; Frostegård J
    J Hypertens; 2002 Sep; 20(9):1815-20. PubMed ID: 12195124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANTI-HSP60 and ANTI-HSP70 antibody levels and micro/ macrovascular complications in type 1 diabetes: the EURODIAB Study.
    Gruden G; Bruno G; Chaturvedi N; Burt D; Pinach S; Schalkwijk C; Stehouwer CD; Witte DR; Fuller JH; Cavallo-Perin P;
    J Intern Med; 2009 Dec; 266(6):527-36. PubMed ID: 19563392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies against phosphatidylserine, prothrombin and phosphatidylserine-prothrombin complex: identical or distinct diagnostic tools for antiphospholipid syndrome?
    Jaskowski TD; Wilson AR; Hill HR; Branch WD; Tebo AE
    Clin Chim Acta; 2009 Dec; 410(1-2):19-24. PubMed ID: 19751711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.